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The purpose of the current study is to understand emotional and neurocognitive 
functioning in childhood cancer survivors. 
 
In this single-evaluation cross sectional study, 41 childhood cancer survivors (53.2% of 
those eligible) in the Health Education Research Outcomes in Survivors (HEROS) Clinic 
at Yale-New Haven Hospital between the ages of six and eighteen and their parents and 
teachers completed the Behavior Assessment System for Children, Second Edition 
(BASC-II), Behavior Rating Inventory of Executive Functioning (BRIEF) and Pediatric 
Quality of Life Inventory (PedsQL). Patient’s, parents’ and teachers’ scores were 
compared to those of normative populations for emotional, neurocognitive and quality of 
life measures. Frequencies of impairment and within population differences in the study 
sample were calculated. Responses by patients were compared to those of parents and 
teachers to determine inter-rater reliability. The patterns of co-existing neurocognitive 
and emotional difficulties in the sample were described. Lastly, elements of emotional 
functioning, neurocognitive impairment, and patient characteristics predictive of impaired 
quality of life were identified with unadjusted and multivariate analyses. 
 
Overall, 56.1% patients were female, the mean age at diagnosis was 3.6 years, and the 
mean age at study completion was 12.8 years. In examining inter-rater reliability, for 
most areas of emotional functioning there was poor agreement (kappa < 0.40). Parents 
and teachers showed moderate agreement in reporting problems with attention (kappa = 
0.57), memory (kappa = .61), and metacognition (kappa = 0.52). Parents and children 
showed greater inter-rater reliability when reporting quality of life than symptoms, with 
agreement in every realm of the PedsQL (kappa > 0.40). Co-morbidities between 
emotional and neurocognitive impairments for the most part did not occur together. 
However, impairments in somatization and withdrawal tended to co-exist with 
impairments in memory, shift and metacognition (p < 0.05). In the multivariate analyses 
looking at social, emotional and school functioning, only neurocognitive functioning was 
a consistent predictor of poor quality of life (OR = 12.94, p = 0.008; OR = 11.48, p = 
0.044; OR = 33.5, p = 0.003, respectively). Poor emotional functioning was also 
predicted by female gender (OR = 15.58, p = 0.025). 
 
Similar to previous studies, a significant proportion of childhood cancer survivors in our 
sample endorse difficulties with internalizing symptoms and executive functions, as well 
as lower physical, emotional and social functioning, than normative populations. The 
current study shows inter-observer variability, especially among indexes of emotional 
symptoms, indicating a need for multiple reporters to determine areas of deficit and true 
levels of functioning. Problems with memory, shift, initiation and coordination of 
problem-solving behaviors co-exist with symptoms of somatization and social 
withdrawal in our study. However, it is the neurocognitive rather than emotional 
symptoms that are shown to be key predictors of how child-age survivors perceive their 
quality of life after therapy. These results highlight neurocognitive impairments as a 
target for intervention during and after treatment for pediatric cancers. 
Acknowledgements 
 During the summer after my first year of medical school I received a summer 
research fellowship to work on this project, which was funded by the Etta S. Chidsey 
Award in Cancer Research through the Yale Cancer Center.  I would like to thank my 
thesis advisor, Dr. Nina Kadan-Lottick, for all of her help and support since we began 
working on the research for my thesis almost three years ago.  She has been a wonderful 
mentor and I have learned a great deal through working with her.  I would also like to 
thank Dr. Natasha Buchanan, a psychology fellow at the Yale Child Study Center.  
Natasha met with me to discuss materials related to my thesis and read drafts of my thesis 
despite always being incredibly busy.  I would like to thank Sheila Santacroce for reading 
my thesis and providing thought-provoking comments on my study and draft.  I want to 
thank Sui Tsang for her assistance with and explanations of the data analysis, and 
Beverly Crowther for helping me to recruit patients when I could not attend clinic myself 
and helping to follow-up with patients.  Lastly, I want to thank my family for their 
constant love and support throughout medical school. 
Table of Contents 
 
Introduction ……………………………………………………………….……...……. 1 
 Emotional and Social Functioning in Childhood Cancer Survivors…………… 2 
 Neurocognitive and School Functioning in Childhood Cancer Survivors……...5  
 Social Cognitive Theory……………………………………………………….. 7 
 
Statement of Purpose and Hypotheses ……………………………………………........ 10 
 
Methods ……………………………………………………………………………….. 12  
 Study Population……………………………………………………………….. 12 
 Participation and Recruitment Procedures……………………………………... 12 
 Study Procedures……………………………………………………………..... 15 
 Study Measures ………………………………………………………………... 16 
 Data Analysis…………………………………………………………………... 23  
 
Results ...…..………………………………………………………………………....… 28 
 Characteristics of the Study Sample...…………………………………………. 28 
 Perceptions of Impairment and Inter-Rater Reliability….....…………………... 40 
 Co-morbidities between Neurocognitive and Emotional Impairments………... 43 
 Predictors of Poor Quality of Life...…………………………………………… 45 
 
Discussion……………………………………………………………………………… 48 
 
Appendix I……………………………………………………………………………... 59 
 
References .…………………………………………………………………………….. 62 
 
 1
Introduction 
 Great strides in treatment of childhood cancer have resulted in dramatic 
improvements in overall survival rates.  With the advent of effective therapies, childhood 
cancer has been transformed from an almost fatal disease to one associated with survival 
rates of almost 80% in patients who are at least five years post-treatment (1, 2).  While 
the rates of survivorship are encouraging, there is now a growing need to determine late 
outcomes in survivors, most of whom received toxic therapies in order to cure their 
malignancies.  Depending on the specific treatments they received, survivors are at 
increased risk for multiple complications later in life, including subsequent malignancies, 
early mortality, growth delay, obesity, pulmonary and cardiovascular disease, and 
infertility (3, 4).   
 Studies have shown that, while the majority of survivors do not experience 
difficulties later in life, a small but significant subset are at increased risk for problems 
related to neurocognitive and psychosocial impairment, including emotional and social 
adjustment (5, 6).  Lower socioeconomic status, less educational attainment, and female 
gender have been identified as potential risk factors (7, 8).  Patients diagnosed during 
adolescence may also be particularly vulnerable to psychosocial distress and difficulties 
with adjustment (9).  Neurocognitive and psychosocial difficulties experienced by 
survivors can have a significant impact on their quality of life, which includes and is 
defined by social and emotional global functioning (2).   
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Emotional and Social Functioning in Childhood Cancer Survivors 
 Based on the improvements in treatment for childhood cancer, survivorship no 
longer refers only to cure rates, but also encompasses the ability of patients to maintain a 
good quality of life after treatment.  Emotional functioning is a crucial component of 
quality of life in survivors, and is defined by an individual’s ability to regulate his or her 
feelings and thoughts, including his or her fears, sadness, anger or worries (5, 6, 10).  
Social functioning is also a key part of quality of life, and encompasses development of 
good and satisfying relationships with peers and feelings of competence in these 
interactions.  Difficulty controlling one’s emotional and social functioning may lead to an 
increase in internalizing symptoms and maladaptive behaviors.  
Internalizing Symptoms 
  Internalizing symptoms include depression, anxiety, withdrawal and somatization.  
Depression is described as a disorder characterized by feelings of sadness, inactivity, 
crying, physical complaints and changes in behaviors that persist over time, affecting an 
individual’s life (11, 12).  Anxiety includes feelings of apprehension or fear that can 
include physical sequelae (13, 14).  Withdrawal refers to detachment from social 
situations, while somatization is described as experiencing over-sensitization to relatively 
minor physical injuries or complaints (7, 13).  Several chemotherapeutic agents have 
been associated with altered behavior, anxiety, and depression in different disease 
populations, and greater treatment intensity has been shown to play a role in development 
of these symptoms in previous studies (8, 15). 
   Overall adult and pediatric survivors experience clinically significant levels of 
depression and anxiety estimated at two- to three-times that of the general population 
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during and after treatment combined (16).  While studies of quality of life and 
psychosocial functioning report that the majority do well, a small but significant group of 
survivors have been shown to experience anxiety, depression and low self-esteem many 
years after treatment (1).  In the Childhood Cancer Survivor Cohort, Zebrack et al. 
evaluated 11,000 patients and showed that 5.4% of patients report symptoms of 
depression compared to 3.4% in the sibling comparison group (8).  In another study, 
parents of 2,979 survivors reported a 1.5-fold increase in depression and anxiety for 
survivors compared to a sibling control group (13).  Children who have survived 
childhood cancer also have been shown to report higher scores on tests that measure 
tension and apprehension than age-matched healthy peers (17).  Recklitis et al. described 
that when screened for psychological distress using the Symptom Checklist-90, 31.7% of 
survivors showed impairments (18).  These studies indicate the existence of internalizing 
symptoms in the population of pediatric cancer survivors, but further understanding of 
the reasons for and impact of this distress is necessary. 
Social Adjustment 
 Childhood cancer survivors have also been shown to exhibit impairments in social 
functioning and adjustment.  Social functioning is the individual’s ability to 
communicate, make friends, and match the pace of peers, as well as the character of his 
or her peer interactions.  Analysis of social functioning includes examining adaptability, 
leadership skills, and tendencies toward withdrawal and atypicality (9).  Previous studies 
have shown that childhood cancer survivors participate in activities less often and spend 
more time by themselves than their siblings and age-matched peers (19).  Furthermore, 
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adolescent survivors have been reported to have a less well-developed sense of identity 
(10).   
 A number of disease and treatment factors have been shown to correlate with 
increased difficulty with social functioning.  Survivors of brain tumors endorse 
impairments in social skills and social adjustment (20).  Children who received cranial 
radiation or intrathecal chemotherapy, such as methotrexate, have been shown to exhibit 
more social and psychological difficulties (14, 21).  In a study of long-term adolescent 
and young adult survivors, with the majority having had leukemia or lymphoma, older 
age at treatment and greater frequency of relapse were also associated with more 
impairments in psychosocial functioning (22). 
 Relationships with peers and family members have also been shown to be affected 
in the survivor population.  Spirito et al reported that survivors have fewer friends (19), 
while Barrera et al. found that survivors were less likely to use friends as confidants than 
healthy children (23).  Survivors may also be less satisfied with their relationships with 
their friends than are their peers, as shown by Gray et al. (24).  Family interactions are 
influenced by a child having cancer.  In one study adolescent survivors reported lower 
levels of family cohesion than healthy controls, with nearly 40% labeling their families as 
disengaged (25).  Perceived family cohesion and social support is strongly related to 
overall psychological well-being in all populations (25, 26). 
 Rates at which survivors achieve independence in adulthood are also altered.  
Outcome studies suggest that, compared to normative populations, survivors are more 
likely to live with their parents and are less likely to marry (27-31).  A large report of 
8,900 patients through the Childhood Cancer Survivor Study showed that survivors are 
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1.6 times less likely to marry than the general population, and 1.8 times less likely than a 
sibling comparison group (32).  This lower marriage rate may indicate deficits in social 
functioning and interactions with peers.    
  
Neurocognitive and School Functioning in Childhood Cancer Survivors 
 Fifty to sixty percent of childhood cancer survivors are also at risk for 
neurocognitive impairments due to the therapies they received (33).  These 
neurocognitive late effects include difficulties with attention, concentration, memory, 
processing speed, and executive function.  Attention and concentration are defined by the 
ability to focus on tasks without distraction (15, 34).  Memory describes an individual’s 
ability to hold on to and recall information (33, 35), and processing speed refers to the 
speed and efficacy with which individuals understand and mentally compute information 
(33).   Executive functions are the processes necessary for organizing and guiding 
behaviors during problem-solving, which include planning, insight, organization and 
initiation of behaviors (33, 36).  Executive functioning is highly correlated with 
neurocognitive functioning, as executive functioning is thought to be located in the 
prefrontal cortex (36).   
 Difficulties with neurocognitive functioning are especially pronounced in 
survivors of cancers of the brain and central nervous system; outcomes are most impaired 
in survivors of brain tumors and acute lymphoblastic leukemia, who generally received 
therapies directed at the central nervous system (33, 37, 38).  Cranial radiation and 
neurotoxic chemotherapeutic agents, including methotrexate, corticosteroids, and 
possibly cytarabine hydrochloride, have been associated with neurocognitive late effects 
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(15, 33, 37, 39).  Younger age at diagnosis and therefore treatment has been associated 
with greater impairment in neurocognitive functioning because of the degree of brain 
maturation at the time of therapy (33).   
 These difficulties can play a role in many aspects of daily functioning, ranging 
from school performance to social interactions, and therefore it is important to understand 
their impact on an individual’s quality of life.  Studies have shown a correlation between 
neurocognitive exposures and poor decision-making leading to risky behaviors (40).   
Neurocognitive and behavioral outcomes are highly interrelated, so neurocognitive 
deficits must be considered when examining psychological and social functioning.   
 Further studies also document reduced school functioning in the population of 
childhood cancer survivors (41).  This includes the ability to pay attention and remember 
information, as well as to regularly attend and keep up with work for school.  Evans et al. 
revealed that 67% of survivors felt that their education had suffered because of their 
cancer (42).  Studies have shown that childhood cancer survivors are more likely to 
repeat grades (7, 24), and that survivors of central nervous system tumors have lower 
school functioning (43).  Even when obtaining similar levels of educational attainment as 
their healthy peers, survivors have reported feeling at a disadvantage because of their 
illness experience and underestimating their abilities, which can negatively affect school 
performance (44, 45).  School functioning plays a role in the individual’s quality of life, 
even outside of the isolated school setting, as children are in part defined by themselves 
and by their peers by their performance in the academic environment.  In some previous 
studies, school functioning has been shown to be the prime determinant of social skills 
and psychological adjustment in pediatric survivors (41). 
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Social Cognitive Theory 
 Social and neurocognitive functioning are important to examine in populations of 
individuals who have undergone treatments for serious illnesses.  However, it is crucial to 
not only understand the treatment-related impairments found in this population, but also 
to examine how these impairments affect the patients’ self-perceptions of their 
performance and quality of life, and this is the goal of the current study.  Psychological 
ability plays a direct role in determination of an individual’s own efficacy expectation.  In 
1977, Albert Bandura described efficacy expectation as “the conviction that one can 
successfully execute the behavior required to produce the outcomes” (46).  He theorized 
that development of self-efficacy is affected by the individual’s experiences and the 
context of his or her life.  Bandura wrote that this expectation ultimately determines how 
an individual is able to develop and exhibit coping behavior, and subsequently also drives 
selection of behaviors (46).   
 Wheeler and Ladd, in developing a scale to analyze the interaction between self-
efficacy and peer relationships, reinforced this concept.  They found that children endorse 
higher levels of  self-efficacy in non-conflict situation, strengthening the notion that an 
individual’s experience shapes his or her self-perceptions (47).  This self-assessment of 
competence also determines how individuals interact with their peers.  Wheeler and Ladd 
theorized that a key aspect of social competence is the individual’s skill at appropriately 
interacting with their peers, and that a high level of social competence is crucial to the 
development of relationships.  They found that anxiety and other emotions are associated 
with self-perception of competence in social behaviors (47).  Harter later added that 
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children tend to judge their social popularity based on how they judge their physical 
abilities and athletic skills (48).  Children analyze their own thoughts, behaviors and 
perceptions of their capabilities, thus determining their self-efficacy and ultimately 
affecting their social interactions.  Negative symptoms endorsed by an individual will 
therefore play a large role in the individual’s experiences and quality of life. 
 Given that self-efficacy is dependent on the individual’s situation and 
environment, children’s self-perceptions are influenced not only by the experience of 
their illness and treatment, but also by those they interact with the most -- their parents 
and guardians.  A child’s self-perceptions may be affected by his or her parents’ attitudes 
and subsequent treatment.  Ladd and Price found in 1986 that parent’s perception of the 
difficulty of a situation had a correlation with the child’s ability to perform a measure, but 
not necessarily the child’s own self-perception of competence (49).  The current study 
aims to further investigate this concept by examining the importance of the reporter -- 
looking at how parents and teachers report children are performing and comparing those 
results to children’s self-reports of their own quality of life.  Understanding these 
differences in perception will serve to describe the forces that help drive how survivors of 
childhood cancer develop their self-efficacy expectation.  Integrating reported levels of 
competence and self-perceptions, and therefore the relationships between impairments 
and self-perception of quality of life, can help target therapies with a goal of improved 
functioning. 
  
 A range of studies have revealed the existence of impairments in childhood cancer 
survivors and other research has detailed the importance of self-efficacy in the 
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development of behaviors.  With the identification of the spectrum of late outcomes, it is 
crucial to move forward and work to understand the effects of these deficits on self-
efficacy and the daily quality of life of survivors.  Survivorship no longer only describes 
cure, it also entails maximizing life experience after treatment.  While it is known that the 
late outcomes of childhood cancer treatments are significant enough to influence quality 
of life, the ways in which this happens have not yet been characterized.  It remains 
unclear which groups are most at risk for psychosocial deficits and what is the relative 
contribution of these impairments in emotional functioning to global quality of life in 
survivors.   
 Building on the work of other studies that have identified areas of deficit, the 
current study simultaneously measures emotional functioning, neurocognitive 
functioning, and quality of life in a small sample size to understand how these deficits in 
functioning predict qualify of life.  Using descriptive data of emotional and 
neurocognitive impairments to characterize the study population, the study compares 
differences in perception depending on the reporter and analyzes emotional and 
neurocognitive deficits to determine co-morbidities.  This information is then used to 
understand predictors of poor quality of life as perceived by childhood cancer survivors. 
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Statement of Purpose and Hypothesis 
 The overall purpose of the current study is to describe and analyze the emotional 
and social functioning of childhood cancer survivors using a sample of patients from the 
Yale University Health Education Research Outcomes for Survivors (HEROS) Clinic.  
Building on the work of previous studies, patients in the present study undergo 
simultaneous measurement of emotional functioning, neurocognitive functioning, and 
quality of life to accomplish three primary aims.   
  First, the study aims to determine if there is inter-rater reliability between 
respondents.  This goal is accomplished by looking at agreement between results of 
parent-, teacher-, and self-reports.  The current study hypothesizes that parents and 
teachers will report impairments in different areas than those self-reported by survivors.   
 Second, the study aims to characterize the co-existence of neurocognitive and 
emotional domains of impairment.  In accomplishing this aim, the study tests the primary 
hypothesis that, as shown by these instruments, impairments in internalizing symptoms, 
emotional symptoms and executive functioning tend to occur together.  It is hypothesized 
that the current study will support the results of previous literature in describing 
emotional and neurocognitive impairments to characterize the study population.  These 
results would indicate that childhood cancer survivors endorse higher levels of 
internalizing symptoms, show impairments in the social domains of adaptability, 
leadership and social skills, and exhibit problems with executive functioning, including 
attention and memory.   
 Third, the study aims to identify factors of impairment in neurocognitive 
functioning, emotional functioning, and patient characteristics that predict worse quality 
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of life as reported by the survivors themselves.  The study hypothesizes that 
neurocognitive and emotional impairments will correlate with and predict lower levels of 
quality of life functioning as shown by the self-report version of the Pediatric Quality of 
Life Inventory.  Lastly, it is hypothesized that, because of the unique developmental 
challenges of transitioning to independence during adolescence, adolescent age at the 
time of testing will predict worse self-perception of quality of life.  Determining the 
predictors of impaired quality of life in the study population, this research hopes to set the 
stage for learning more about possible areas and methods of therapeutic intervention both 
during and after treatment. 
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Methods 
Study Population 
Eligibility for participation in this cross-sectional study was limited to patients 
enrolled in the Yale University Health Education Research Outcomes for Survivors 
(HEROS) Clinic.  Attendees of the HEROS clinic must be in remission and at least three 
years post-diagnosis of their primary malignancy.  Eligibility was restricted to patients 
aged six to eighteen years of age who either spoke English of Spanish.  These criteria 
match the age ranges and languages for which the survey instruments were available.  In 
addition, the parent or guardian was required to have a written knowledge of English or 
Spanish.  Children who could not yet read could have the surveys read to them by a 
parent, guardian or member of the research team.   
Prior to initiation of this study, the co-investigator for this study, Tamara Porter 
Miller, completed and submitted an application to the Human Investigations Committee 
with the assistance of the principal investigator, Dr. Nina Kadan-Lottick.1  This protocol 
was approved on first review. 
 
Participation and Recruitment Procedures 
Patient recruitment began on July 19, 2005 and completed when the study closed 
on November 30, 2008.  Patients and their families were approached about participation 
in the present study during their routine annual appointments by the co-investigator or a 
member of the HEROS Clinic staff.  The co-investigator trained clinic staff to describe 
                                                 
1 The Principal Investigator for the current study was Dr. Nina Kadan-Lottick, M.D., M.S.P.H.  The co-
investigator was Tamara Porter Miller.  Clinic staff also assisted in the execution of the present study.  
These staff members included Beverly Crowther M.Ed., Sheila Santacroce, Ph.D., Jodi Emir, R.N., and 
Kim Trotta, R.N.  Additional guidance and assistance with data analysis was provided by other members of 
the HEROS Clinic Team, including Sui Tsang and Dr. Natasha Buchanan, Ph.D. 
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and consent patients for the study prior to study recruitment.  If interested, the risks and 
benefits of the study were discussed.  The parent and child then signed consent and assent 
forms respectively, as well as a research authorization form, while in the clinic waiting 
room.  These consent and research authorization forms were written by the co-
investigator and principal investigator and were approved each year by the Human 
Investigations Committee prior to use.   
The parent and children were given the survey instruments to complete while 
waiting for their appointments.  The parents were also given a survey that they were 
instructed to give to the most recent teacher who knew their child best.  This survey was 
attached to a stamped, addressed envelope in which the teacher could return the survey.  
Parents and children could decline to include a recent teacher in the study and still 
participate in the study.  The co-investigator or a trained HEROS clinic staff member was 
available at all times during the visit to answer questions about the consent process, risks 
and benefits, and survey instruments.  The parents and children were given a phone 
number to call with questions. 
When recruited in clinic the majority of patients did not have enough time to 
complete the surveys, and took the packets of questionnaires home to complete and return 
in self-addressed, stamped envelopes.  Per protocol, as approved by the Human 
Investigations Committee, patients were contacted by phone if they had not returned the 
questionnaires.  Families were asked if they had any questions about the surveys and 
were encouraged to send the packets back as soon as possible.  If necessary, a second 
packet of surveys was sent.  In rare cases, the patiens and their parents did not complete 
the packets for the entire year between recruitment and their regularly scheduled clinic 
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appointment the following year.  In these situations, the patients were called prior to the 
visit and asked to bring the completed surveys with them, or were re-recruited at the 
second clinic visit. 
Patients were also recruited by mail, as approved by an amendment to the original 
protocol accepted by the Human Investigations Committee.  At the end of the first 
summer of recruitment, in September, 2005, the co-investigator sent packets to every 
current patient in the HEROS Clinic who had not already been recruited in clinic.  These 
packets included a letter explaining the study, age-appropriate assent and consent forms 
for the patients and their parents, the research authorization form, age-appropriate study 
instruments, and two addressed, stamped envelopes.  Prior to distribution of the packets, 
each member of the HEROS Clinic was assigned a Clinic identification number.  This 
number was written on the survey instruments in place of the patient name in order to 
provide anonymity.  The envelopes in the package were addressed directly to the 
Principal Investigator.   
The patients and parents were asked to put the signed consent and assent forms, 
the signed research authorization form, and the completed surveys into the large envelope 
and to return it as soon as possible.  The smaller envelope in the packet was for the 
family to give to the most recent teacher who knew the child best.  When received at 
Yale, the consent and authorization forms were separated in order to ensure future 
confidentiality.  All further analyses of the data in the surveys were performed based on 
HEROS Clinic identification number instead of patient name.  
A number was provided in the recruitment letter for patients to call with questions 
or to decline participation.  If patients had not called to refuse participation, they were 
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contacted with two further mailings and, if they came to clinic for their regularly 
scheduled appointments, were approached in person.  Per protocol approved by the 
Human Investigations Committee, patients and their families could also be contacted by 
phone after the second mailing if they had not returned the packets or called to decline 
participation to determine if they had any questions.  It was made clear both in the 
mailing letter and during recruitment in clinic that refusal to participate would not affect 
the child or family’s relationship with their doctors in the HEROS Clinic. 
Despite efforts to follow-up with patients and encourage return of packets, three 
families who had consented to participate did not return the surveys before the study 
period ended and were categorized as passive refusals.  In addition, two families reported 
mailing packets that were never received.  These families were approached about 
repeating the surveys, but declined to do so. 
 
Study Procedures 
The self-report surveys took child respondents approximately fifteen to twenty 
minutes to complete, and parent and teacher respondents thirty to forty minutes to 
complete.  Participants were informed that each child would be assigned an identification 
number so that their names would not be directly listed on the surveys with their 
responses.  Once completed, surveys were stored in a locked area separately from the 
consent forms to maintain confidentiality.   
The patient, parent and identified teacher all completed age-appropriate and 
audience-specific versions of the Behavior Assessment System for Children, Second 
Edition (BASC-II).  The parent and teacher completed parent- and teacher-versions of the 
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Behavior Rating Inventory of Executive Function (BRIEF).  The parent and child also 
completed age-appropriate parent- and child-versions, respectively, of the Pediatric 
Quality of Life Inventory, Version 4.0 (PedsQL).  The parent answered an intake 
questionnaire, the Family and Social History Questionnaire, collecting information about 
family, social, school, pre-treatment, birth and cancer treatment history. 
Patients enrolled in the HEROS clinic were asked a variety of demographic, 
family and social history, and treatment-history related questions during their initial visit.  
This information, combined with information in the patient’s medical record related to 
their diagnosis and treatment history, was compiled in the HEROS Clinic database.  
Information in this database was collected for the patients enrolled in the present study 
and used to stratify and characterize patients during the analysis.  This data included 
information about the primary diagnosis, subsequent malignancies, chemotherapy and 
radiation history, and complications and outcome history.  
 
Study Measures  
Behavior Assessment Scale for Children, Second Edition (BASC-II) 
The BASC-II (Reynolds, CR and Kamphaus, RW, 2004) is a set of surveys that 
examines adaptive and maladaptive behaviors, thoughts and emotions of children and 
adolescents (50).  The BASC-II is often used to examine affective and mood disorders in 
children as perceived from the parent’s and teacher’s point of view or as self-reported 
from the child.   
Self-, teacher- and parent-report versions of the BASC-II were used in the age 
categories between ages six and eighteen years.  The SRP-C, a self report for ages eight 
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through eleven, has 139 items.  The SRP-A, a self report for age twelve through twenty-
one, has 176 items.  The PRS-C, or parent rating scale for ages six through eleven, has 
160 items.  The PRS-A, completed by parents for their children aged twelve to twenty-
one has 150 questions.  The teacher versions, the TRS-C for ages six to eleven and the 
TRS-A for ages twelve to twenty-one, each have 139 items.  The parent, teacher or child 
completing the survey is asked to read each statement and mark the response that best 
describes how the child has acted over the previous six months (never, sometimes, often, 
or always).  The self-report version also requires the child to respond to a series of true or 
false questions.     
On the parent and teacher versions, the scales are divided as described below.  
The first scale, Externalizing Problems, includes Aggression, Hyperactivity and Conduct 
Problems.  The second scale, Internalizing Problems, includes Anxiety, Depression, and 
Somatization.  The next scale, School Problems, includes Attention Problems and 
Learning Problems.  The Adaptive Scale includes Adaptability, Leadership, Social Skills 
and Study Skills.  There is also an Atypicality scale that is used with Withdrawal and 
Social Skills to gauge unusual behaviors and impaired relations. Lastly, there is a broad 
scale called the Behavioral Symptoms Index; this includes Hyperactivity, Aggression, 
Depression, Attention Problems, Atypicality, and Withdrawal.  There is also a subscale 
called Activities of Daily Living, which analyzes the individual’s skills at completing 
routine daily tasks, and a subscale called Functional Communication, which evaluates the  
ability to effectively communicate thoughts and ideas (50) (for definitions of each scale, 
see Table 1). 
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Table 1 - Definitions of Scales on the Behavior Assessment Scale for Children, 
Second Edition (50) 
Scale Definition 
Externalizing Problems   
     Aggression Behaviors of physical or emotional harm towards others 
     Hyperactivity Impulsive and excessively active tendencies 
     Conduct Problems Disruptive behaviors in school or at home 
Internalizing Problems   
     Anxiety Feelings of apprehension or fear that can include physical sequelae (13, 14) 
     Depression Feelings of sadness, inactivity, crying, or changes in behavior (11, 12) 
     Somatization Over-sensitization to relatively minor physical injuries or complaints (7, 13) 
     Atypicality Behaviors that are unusual for the child’s age 
     Locus of Control Control over external situations, only on self-report 
     Social Stress Tension and anxiety felt by children in social situations, only on self-report 
     Sense of Inadequacy Self-perceptions of ability, only on the self-report 
School Problems   
     Attention Problems Difficulties with maintaining focus and ease of distractibility 
     Learning Problems Deficits in understanding academic problems and obtaining high levels of academic achievement 
Adaptive Skills Composite   
     Adaptability The ability to change and to positively react to change 
     Social Skills Interactions with others 
     Leadership Tendencies to take charge when working with others 
     Study Skills Abilities in an academic setting 
Personal Adjustment   
     Relations with Parents Interactions with parents, only on self-report 
     Interpersonal Relations Interactions with peers, only on self-report 
     Self esteem The child’s happiness with his or her self, only on self-report 
     Self-Reliance Self-perception of decision making capability, only on self-report 
Withdrawal Behaviors of social avoidance and being reclusive 
Activities of Daily Living The individual’s skills at completing routine daily tasks 
Functional Communication The ability to effectively communicate thoughts and ideas 
Behavioral Symptoms 
Index   
 
On the self-report the first scale is School Problems, and includes Attitude to 
School, Attitude to Teachers and Sensation Seeking.  The Internalizing Symptoms scale 
includes Atypicality, Locus of Control, Social Stress, Anxiety, Depression, Sense of 
Inadequacy and Somatization.  The Inatttention/Hyperactivity scale includes Attention 
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Problems and Hyperactivity.  The Emotional Symptoms Index is a broad scale that 
includes Social Stress, Anxiety, Depression, Sense of Inadequacy, Self-Esteem and Self-
Reliance.  Lastly, the Personal Adjustment scale includes Relations with Parents, 
Interpersonal Relations, Self-Esteem and Self-Reliance (50) (for definitions of each scale, 
see Table 1). 
 Answers to the survey questions are inputted into a computer program that 
calculates the scaled scores for each index.  Scores were compared to the general, 
combined sex normative population.  The Adaptive Scales include Functional 
Communication, Adaptability, Activities of Daily Living, Leadership, Social Skills and 
Study Skills; the other scales are considered Clinical Scales.  In scoring the surveys, T-
scores on the Adaptive Scales are considered at-risk below forty and clinically significant 
at thirty and below.  For the Clinical Scales T-scores are considered at-risk when greater 
than sixty and clinically significant when greater than seventy (50).  
The BASC-II has been used in a variety of populations to analyze emotional and 
behavioral problems in children.  These groups have included healthy children, children 
with a range of illnesses, and children from a variety of socioeconomic and ethnic 
backgrounds.   The instrument has been compared to other assessment surveys and been 
shown to be a valid and useful tool for maladaptive behaviors.  Reliability was studied by 
the authors.  Reliability scores for the teacher version ranged from 0.85 to 0.95, with 
composite scores having the highest reliability.  Reliability scores are reported by the 
authors to range from 0.83 to 0.87 for the parent version and the mid-0.70s to the mid-
0.80s for the self-report version (51). 
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Behavior Rating Inventory of Executive Function (BRIEF)  
The BRIEF (Gioia, GA, Isquith, PK, Guy, SC, Kenworthy, L, 2000) is a parent- 
and teacher-completed instrument that assesses the child’s emotional control, ability to 
inhibit and short attention, initiation, working memory, planning, and organization of 
materials (36).  There is one parent version and one teacher version; the scaled score 
adjusts for the age of the individual.  It is an 86-item questionnaire divided into eight 
clinical scales and two validity scales.  These are grouped into two broader indexes of 
Behavioral Regulation and Metacognition.  The parent or teacher is asked to read each 
statement and answer how much of a problem the child has had with each statement in 
the previous six months (never, sometimes, often).   
 The results are tallied and the raw scores are converted to scaled, or T-scores.  
The results are divided into the following scales: the Behavioral Regulation Index (BRI) 
and the Metacognition Index (MI).  The BRI includes the subscales of Inhibit, Shift, and 
Emotional Control, and describes the individual’s ability to appropriately control and 
modulate emotions and behaviors.  The MI includes the subscales of Initiate, Working 
Memory, Plan/Organize, Organization of Materials, Monitor.  The MI reveals the child’s 
ability to start, arrange and coordinate problem solving in working memory.  All of the 
subscales are combined into one summary scale, the Global Executive Composite (GEC) 
(36) (for definitions of each scale, see Table 2).   
 The T-scores are compared to a standardization sample to determine if the results 
are clinically significant.  Higher T-scores indicate more problems with executive 
function.  In evaluation of results from both the teacher and parent versions of the 
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Table 2 - Definitions of Scales on the Behavior Rating Inventory of Executive 
Functioning (36) 
Scale Definition 
Behavioral Regulation Index 
 
The ability to appropriately control and modulate emotions and 
behaviors 
     Inhibit The ability to control impulses and stop behavior 
     Shift 
 
Aptitude in moving freely between activities and problem-solving 
flexibility 
     Emotional Control Emotional regulation and expression of executive functioning  
Metacognition Index 
 
The ability to start, arrange and coordinate problem solving in working 
memory 
     Initiate The ability to begin activities and generate ideas 
     Working Memory The ability to retain and recall information during problem solving 
     Plan/Organize The ability to coordinate tasks 
     Organization of Materials The tidiness of a child’s work and play areas 
     Monitor The tendency to check work and assess one's own performance 
Global Executive Composite Summary analysis of executive functioning 
 
BRIEF, T-scores equal to or greater than 65 are considered at risk for clinical 
significance on all scales (36). 
The BRIEF was normalized with a set of 1419 parent forms and 720 teacher 
forms.  The sample represented both genders and a broad socioeconomic and ethnically-
diverse group (52).  The reliability and validity for the BRIEF were studied and are 
reported in the manual for the study instrument.  Content and construct validity were 
studied by the authors and a group of neuro-psychologists.  The reliability scores, which 
measure internal consistency, ranged from 0.80 to 0.98 for both the parent and teacher 
versions of the BRIEF (36, 52). 
 
Pediatric Quality of Life Inventory, Version 4.0 (PedsQL) 
The PedsQL (Varni, JW, 1998) is a global quality of life survey that assesses 
children’s emotional and social status. It is intended to be given to both healthy 
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populations and children with acute and chronic diseases.  It is intended to distinguish 
between these populations and determine disease severity within the group of children 
with chronic illnesses.  The instrument includes parent and child versions for each age 
group.  The current study used the surveys targeted for the ages 5-7, 8-12, and 13-18.  
The PedsQL is a twenty-three-item survey divided into four sections: physical 
functioning, emotional functioning, social functioning, and school functioning.  There are 
eight questions about physical functioning, and five questions in each of the other three 
categories.  
The parent or child is asked to read each statement on the questionnaire and mark 
the response that best describes how much of a problem the statement has been in the 
previous month (never, almost never, sometimes, often, almost always).  The answers are 
converted to numerical z-scores.  They are tabulated to give a Total Scale Score, a 
Physical Health Summary Score (eight items), and a Psychosocial Health Summary Score 
(fifteen items).  Higher z-scores correlate with better quality of life.  Lower z-scores 
indicate reports of worse quality of life.  In the current study physical functioning data 
was obtained but not used for further analysis, as this was out of the scope of this 
research. 
The author of the PedsQL studied the reliability and validity of the instrument in a 
population of 963 children and 1629 parents.  Varni et al. found that there was internal 
consistency reliability for the Total Scale Score of 0.88 for the child surveys and 0.90 for 
the parent surveys.  Validity was proven through positive correlations with indicators of 
mortality and illness burden and through ability to distinguish between healthy and sick 
 23
children (53).  The PedsQL was analyzed in an ethnically diverse and socio-economically 
heterogeneous populations of healthy and sick children (53). 
 
Family and Social History Questionnaire 
The Family and Social History Questionnaire is an intake survey written by the 
co-investigator and principal investigator and completed by the parent.  The survey aims 
to collect demographic data and information about the child’s school and treatment 
history.  It was used to stratify results from the other surveys by patient characteristics.  
This data was used with the information from the HEROS database to understand the 
type of cancer and therapy each child received, as well as the child’s daily living 
situation.  Data collected included: Race, Living Situation (Parents divorced/married, 
Siblings, Who Lives at home, Who is the primary caregiver), Present age, Current grade, 
If the child attended school during therapy, What type of school the child attends, If and 
what type of special education services the child receives, Medication history and current 
medications (Anti-depressants, Ritalin, etc.), and History of mental health services 
(Psychotherapy, Behavioral Therapy, Psychotropic drugs). 
 
Data Analysis 
The pattern of impairment in the study population was described in order to 
characterize the population and to be used for further analyses.  This was accomplished 
by comparing the data from the BASC-II, BRIEF and PedsQL to the scores of published 
age- and gender-specific normative populations.  Two-sided one sample student T tests 
were then conducted to compare observed frequency of impairment in the research 
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population with the expected proportions in the general population.  Outcomes were 
examined as mean scores as well as percentages of the population in the impaired range. 
Percentages of impairment were compared using Fisher’s test to evaluate for significant 
differences between groups.  P-values less than 0.05 were considered statistically 
significant. 
In order to further describe the emotional, neurocognitive and quality of life 
functioning in the study population, children were divided by gender and by age at 
diagnosis of less than 3.5 years of age or greater than or equal to 3.5 years of age.  Age at 
diagnosis was analyzed because previous literature has shown that younger age at 
diagnosis impacts symptoms of late effects, especially in neurocognitive functioning.  
The age cutoff was chosen because, in the current study population, the mean was 3.6 
years and the median was 3.4 years.   
Patients were also analyzed by age at study completion because prior studies 
indicate different presentation of late effects in adolescents and younger populations.  
Adolescent age was considered from twelve to eighteen years of age and pre-adolescent 
age was six through eleven years of age.  This was determined using the age breakdowns 
of “Child” and “Adolescent” on the BASC-II.  Patients were also divided based on their 
receipt of central nervous system-directed therapies, which included intrathecal 
chemotherapy and cranial irradiation.   
To accomplish the first aim of the study -- to describe inter-rater reliability -- 
kappa statistics analyzed agreement of perceptions reported on the parent, teacher and 
self-report versions of the survey instruments.  Inter-rater reliability for a given scale was 
evaluated to produce kappa coefficients, which are measures of agreement.  Kappa 
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coefficients of 0.41 to 0.60 were considered moderate strength of agreement, and values 
of 0.61 to 0.80 were considered substantial strength of agreement.  A kappa value 
between 0.81 and 1.00 was considered almost perfect strength of agreement (54).  P-
values were used to determine if the agreement was due to chance. 
Specifically, the attention scales on the parent and teacher versions of the BASC-
II were analyzed.  Parent and self-report versions of the BASC-II were evaluated for 
agreement on the scales of depression, anxiety, withdrawal, somatization, attention and 
internalizing problems.  Inter-observer reliability between parent and teacher perceptions 
of executive functioning were analyzed with reports on the BRIEF of memory, inhibition, 
shift, planning and organization, initiation, monitor, the Metacognition Index (MI) and 
Global Executive Cognition (GEC).  Parent and child perceptions of quality of life were 
analyzed for agreement using the parent and self-report versions of the PedsQL on the 
school, emotional and social functioning scales.  The physical functioning scale was not 
examined because it was out of the scope of this study.  There is no teacher-report 
version of the PedsQL.  To understand different perceptions of school functioning 
between teachers and children, self-report of school functioning on the PedsQL was 
evaluated for agreement with teacher-report on the BRIEF of problems with memory, 
planning, initiation, and organization of materials. 
The second aim of the current study is to characterize co-morbidities between 
neurocognitive and emotional problems.  To accomplish this goal, two-by-two 
comparison analyses were created evaluating specific scales on different survey 
instruments.  Among the group of parents reporting impairment in an emotional outcome, 
the percentage of parents reporting co-existing impairment in a given neurocognitive 
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outcome was assessed.  Fisher’s tests were run to determine the presence of a significant 
association with p-values less than 0.5 showing statistically significant association.  Chi-
square analysis could not be performed due to the small sample size of the study. 
Using the descriptive data of emotional and neurocognitive functioning in the 
study population from the study instruments, anxiety and depression, somatization, 
withdrawal and internalizing symptoms on the parent-report BASC-II were each 
compared in two-by-two tables to the memory, organization of materials, initiation, shift, 
monitor, inhibition and metacognition index scales on the parent version of the BRIEF.  
To determine these co-morbidities, the parent versions of the BASC-II and BRIEF were 
used.  The parent versions were utilized due to the parent’s ability to examine the child in 
several environments.  This was chosen based on previous literature using parent-report 
to analyze behaviors in childhood cancer survivors (2, 19).  While parent-report cannot 
provide a sole substitute for child-report, it has been shown to be a useful and valid 
measure (55).   For consistency, the parent versions were used in all further analyses 
examining endorsement of symptoms.  Self-report could not used because the BRIEF, the 
most reliable and valid measure of problems with neurocognition used in this study, does 
not include a self-report version.   
 The study’s third aim is to identify factors that predict poor quality of life 
functioning.  To accomplish this aim an unadjusted and adjusted multivariate analysis 
was performed.  The parent- report versions of the BASC-II and BRIEF were used for 
these analyses.  However, the self-report version of the PedsQL, the quality of life 
inventory, was selected to obtain the best understanding of the effects of impairments on 
childhood cancer survivors. 
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The demographic predictors of female gender and adolescent age were selected to 
be analyzed as predictors of poor quality of life.  These were selected based on reports in 
the literature and the results of the current study showing greater impairments in these 
populations.  Age at diagnosis and age at study completion were shown by this and 
previous studies to be correlated, and age at testing is considered a better determinant of 
functioning, so it was chosen for the multivariate analysis.  Additionally, in order to test 
the hypothesis that endorsement of internalizing symptoms and problems with executive 
functioning predict lower quality of life, parent rating of impairment on the internalizing 
symptoms scale on the BASC-II  and parent rating of impairment on the metacognition 
index of the BRIEF were used in the linear regression.  The internalizing symptoms scale 
on the BASC-II was selected as a strong measure of emotional functioning, and the 
metacognition index on the BRIEF was chosen as a good overall measure of 
neurocognitive function.  These demographic and symptom predictors were used to 
analyze the scales of school functioning, emotional functioning and social functioning on 
the self-report PedsQL via an unadjusted and adjusted linear regression. 
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Results 
Characteristics of the Study Sample 
 Forty-one of the seventy-seven (53.2%) patients contacted consented to 
participate in the current study.  A combined twenty-seven (35.1%) patients actively or 
passively refused participation.  Three patients out of the seventy-seven contacted (3.9%) 
were recruited and consented to participate, but never returned the study instruments.  
Two (2.6%) of the contacted patients consented to participate and reported putting the 
completed surveys in the mail, but these surveys were never received.  These patients 
were approached about re-completing the surveys but declined to do so; these packets are 
considered lost in the mail.  Four (5.2%) recruited patients were deemed to be ineligible 
(see Figure 1).  Of these recruited, ten (24.4%) were recruited by mail and twenty-four 
(58.5%) were recruited in clinic.  Seven (17.1%) of those recruited were contacted by 
mail and did not respond, but were later recruited in clinic (see Figure 1).    
 Of the twenty-seven who refused participation, seven (25.9%) actively refused 
participation in the study in clinic.  Fourteen (51.9% of refusals) patients who were sent 
packets never responded nor came to clinic, and are considered passive refusals.  Six 
patients (22.2% of refusals) who were mailed surveys did not respond or have clinic 
appointments before they turned nineteen, which was too old for the study; these patients 
aged-out and are also considered passive refusals (see Figure 1).   
 The mean age at diagnosis in the study population was 3.63 years, with a standard 
deviation of 2.55 and a range of zero to 12.66 years (see Table 3).  The median was 3.37 
years.  The age at diagnosis was skewed to the left, with 23 patients (56.1%) diagnosed 
before age 3.5, and 18 (43.9%) diagnosed at age 3.5 or older.   
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Figure 1 - Diagram Showing Success of Study Recruitment and Reasons for Refusal 
of Participation 
 
 
 
  
 The mean age at testing, defined as the time of study completion by the parent, 
child and teacher, was 12.85, with a standard deviation of 3.54 and a range of 6.67 to 
18.98 years.  Patients were considered too old for the current study once they turned 
nineteen.  Sixteen (39%) of patients were pre-adolescent, defined as ages six through 
eleven, and 25 (61%) were adolescents, aged twelve through eighteen (see Table 3).  The 
variation in age at testing was great, with the most numbers of patients aged nine, twelve 
and fourteen, with five patients each.  The mean age since completion of cancer treatment 
was 9.21 years, with a standard deviation of 3.53 and a range of 4.16 to 16.37 years. 
 The largest group of patients was white; thirty-two (78.1%) of the patients studied 
were Caucasian and non-Hispanic.  Five (12.2%) were Hispanic and two (4.9%) were 
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Table 3 – Comparison of Participants and Non-Participants in Terms of 
Demographics and Treatment Factors A 
 Participants 
N (%) 
Non-Participants 
N (%) 
p-
value 
Gender 
     Female 
     Male 
 
23 (56.1%) 
18 (43.9%) 
 
12 (44.4%) 
15 (55.6%) 
 
0.458 
Ethnicity 
    White 
    Non-WhiteB 
      Unknown 
 
36 (87.8%) 
4 (9.8%) 
1 (2.4%) 
 
16 (88.9%) 
2 (11.1%) 
 
 
0.831 
Household Income 
     < $40,000 
     $40,000 - $80,000 
     > $80,000 
     Unknown 
 
3 (7.3%) 
13 (31.7%) 
18 (43.9%) 
7 (17.1%) 
  
Cancer Diagnosis 
     ALL 
     Central Nervous System Tumor 
     Sarcoma 
     Neuroblastoma 
     Wilm’s Tumor 
     Non-Hodgkin’s Lymphoma 
     Hodgkin’s Lymphoma 
     Other 
 
21 (51.2%) 
4 (9.8%) 
4 (9.8%) 
3 (7.3%) 
3 (7.3%) 
1 (2.4%) 
1 (2.4%) 
4 (9.8%) 
 
7 (26%) 
0 
3 (11.1%) 
4 (14.8%) 
6 (22.2%) 
6 (22.2%) 
0 
1 (3.7%) 
 
0.014 
 
CNS-Directed Treatment  
     CNS-Directed TreatmentC 
     No CNS-Directed Treatment 
 
25 (62.5%) 
15 (37.5%) 
 
7 (25.9%) 
20 (74.1%) 
 
Treatment History 
     Chemotherapy Only 
     Chemotherapy and Radiation 
     No Chemotherapy or Radiation 
 
25 (61%) 
14 (34.1%) 
2 (4.9%) 
 
6 (22.2%) 
6 (22.2%) 
15 (55.6%) 
 
0.000 
Mean Age at Diagnosis ± SD (Range) in Years 3.6 ± 2.6 (0-12.7) 3.2 ± 2.7 0.554 
Mean Age at Time of Study Opening ± (Range) 
in Years 
12.0 ±  3.7 (6.7-
18.99) 
14.5 ± 2.9 0.004 
Mean Age at Study Completion ± SD (Range) in 
Years 
12.8 ± 3.5 (6.7 – 
18.99) 
  
Time Since Therapy Completion in YearsD 
     0-4 
     5-9 
     10-14 
     >15 
 
15 (38.5%) 
15 (38.5%) 
8 (20.5%) 
1 (2.5%) 
 
0 (0%) 
6 (54.6%) 
4 (36.4%) 
1 (9%) 
 
 
0.041 
A - Bold numbers indicate statistical significance. 
B - Non-white includes African-American, Hispanic, Central American Indian and other. 
C -  CNS-Directed Therapy includes intrathecal chemotherapy or cranial radiation.  In the group of 
participants, twenty-one patients received intrathecal chemotherapy and six patients received cranial 
radiation. 
D – Years since therapy completion was determined using the date of study completion for 
participants and using the date on which the study was opened for non-participants.  Data about the 
date of therapy completion was only available for 11 non-participants. 
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African-American.  One (2.4%) patient refused to answer and one (2.4%) was listed as 
other (see Table 3). 
 Parents reported their total family income on the Family and Social History 
Questionnaire.  The majority of parents, eighteen (43.9%), listed their annual family 
income as greater than 80,000 per year.  Eight (19.5%) reported income of 60,000 to 
80,000.  Five (12.2%) listed their incomes as 40,000 to 60,000, and three (7.3%) as less 
than 40,000 annually.  Three (7.3%) patients refused to answer and four (9.8%) reported 
that they did not know their average annual income (see Table 3). 
 The study population included a wide range of cancer diagnoses.  Twenty-one 
patients (51.2%) were diagnosed with acute lymphoblastic leukemia.  Four patients 
(9.8%) had been diagnosed with sarcomas and four patients (9.8%) with tumors of the 
central nervous system.  Three patients (7.3%) were diagnosed with each of the following 
cancers: Neuroblastoma and Wilm’s tumor.  Two patients (4.8%) were diagnosed with 
lymphomas, one patient with Hodgkin’s Lymphoma and one patient with Non-Hodgkin’s 
Lymphoma.  Four patients (9.8%) had other cancers (see Table 3). 
 Of these patients participating in the study, twenty-five (61%) received only 
chemotherapy.  Fourteen (34.1%) of the patients received both chemotherapy and 
radiation.  Two (4.9%) patients received neither chemotherapy nor radiation as part of 
their cancer treatment (see Table 3). 
 The group of participants was compared to those who declined participation in the 
present study.  There were no significant differences in the two populations in terms of 
gender, ethnicity, or age at diagnosis.  In the participant group twenty-three (56.1%) were 
female, while in the non-participant group twelve (44.4%) were female.  There was a 
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significant difference in the age at testing.  The mean age in the study population was 
12.0 years, while the mean age at time of study opening in the non-participant group was 
14.5 (p-value = 0.004) (see Table 3).   
 The set of diagnoses was significantly different (p-value = 0.014) when 
comparing overall range of diagnoses for each group.  The study population had a greater 
percentage of patients with acute lymphoblastic leukemia (51.2%) than the non-
participant group (25.9%).  Diagnoses of Neuroblastoma (7.3% in the study population), 
Wilm’s tumor (7.3%), and Non-Hodgkin Lymphoma (2.4%) were underrepresented in 
the group of participants (14.8%, 22.2% and 22.2% respectively in the non-participant 
group).  Of the forty patients for which data was available, twenty-five (62.5%) 
participants received central nervous system-directed therapy, which included either 
cranial radiation or intrathecal chemotherapy, and fifteen (37.5%) did not.  This was 
different from the non-participant group, in which seven (25.9%) received central 
nervous system-directed therapies and twenty (74.1%) did not.  Analyses of treatment 
and years since therapy completion in the non-participant group was confounded by 
missing information, as complete data was available for only a minority of non-
participants (see Table 3). 
 When analyzing the data in order to describe the study population, the mean 
values in the sample were in the standard range reported for each survey instrument.  
However, when examining percentage of impairment compared to the expected in a 
normative population, there were significant differences.  Therefore percentages of 
impairment and their respective significance, as indicated by p-values less than 0.05, are 
reported throughout the text and tables. 
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Table 4 - Emotional Functioning as Measured by the Parent Version of the Behavior 
Assessment Scale for Children, Second Edition (BASC-II), Stratified by GenderA 
   Norm All patients Female Male 
  % #/N % 
p-
value #/N % 
p-
value #/N % 
p-
value 
Externalizing 
Problems 16 5/40 12.5 0.670 3/22 13.6 1 2/18 11.1 0.756 
     Hyperactivity 16 5/40 12.5 0.670 2/22 9.1 0.562 3/18 16.7 1 
     Aggression 16 4/40 10 0.391 3/22 13.6 1 1/18 5.6 0.34 
     Conduct 
Problems 16 7/40 17.5 0.828 4/22 18.2 0.77 3/18 16.7 1 
Internalizing 
Problems 16 11/40 27.5 0.053 9/22 40.9 0.005 2/18 11.1 0.756 
     Anxiety 16 7/40 17.5 0.828 5/22 22.7 0.382 2/18 11.1 0.756 
     Depression 16 13/40 32.5 0.008 9/22 40.9 0.005 4/18 22.2 0.515 
     Somatization 16 13/40 32.5 0.008 9/22 40.9 0.005 4/18 22.2 0.515 
Behavioral 
Symptoms Index 16 11/40 27.5 0.053 5/22 22.7 0.382 6/18 33.3 0.055 
     Atypicality 16 9/40 22.5 0.278 3/22 13.6 1 6/18 33.3 0.055 
     Withdrawal 16 12/40 30.0 0.027 8/22 36.4 0.017 4/18 22.2 0.515 
     Attention 
Problems 16 11/40 27.5 0.053 5/22 22.7 0.382 6/18 33.3 0.055 
Adaptive Skills 
Composite 16 10/40 22.5 0.278 5/22 22.7 0.382 5/18 27.8 0.192 
     Adaptability 16 9/40 22.5 0.278 6/22 27.3 0.149 3/18 16.7 1 
     Social Skills 16 7/40 17.5 0.828 3/22 13.6 1 4/18 22.2 0.515 
     Leadership 16 8/40 20.0 0.515 4/22 18.2 0.77 4/18 22.2 0.515 
     Activities of 
Daily Living 16 9/40 22.5 0.278 3/22 13.6 1 6/18 33.3 0.055 
     Functional 
Communication 16 9/40 22.5 0.278 5/22 22.7 0.382 4/18 22.2 0.515 
Significance is determined if the percentage of study patients with T scores ≥ 84 percentile (≤ 16 
percentile for adaptive scales) is greater than the expected 16%. 
A - Bold numbers indicate statistical significance. 
 
 The data from the BASC-II was analyzed to characterize impairments in 
emotional functioning in the study population.  Using the parent reports of their 
children’s behavior on the BASC-II, 27.5% reported impairments in internalizing 
symptoms, with clinically significant endorsement of symptoms of depression (32.5%), 
somatization (32.5%) and withdrawal (30.0%).  In addition, 27.5% showed impairments 
in attention and 27.5% endorsed symptoms of impairment on the behavioral symptoms 
index compared to normative populations (see Table 4). 
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Table 5 - Neurocognitive and Executive Functioning as Measured by the Parent 
Version of the Behavior Rating Index of Executive Functioning (BRIEF), Stratified 
by GenderA  
  Norm All Patients Female Male 
  % #/N % 
p (vs. 
norm) #/N % 
p (vs. 
norm) #/N % 
p (vs. 
norm) 
Inhibit 10 8/38 21.1 0.05 5/21 23.8 0.052 3/17 17.6 0.238 
Shift 10 13/38 34.2 0.000 7/21 33.3 0.003 6/17 35.3 0.005 
Emotional 
Control 10 7/38 18.4 0.098 4/21 19.0 0.152 3/17 17.6 0.238 
BRI 10 12/38 31.5 0.000 7/21 33.3 0.003 5/17 29.4 0.022 
Initiation 10 6/38 15.8 0.270 2/21 9.5 1 4/17 23.5 0.083 
Working 
Memory 10 13/37 35.1 0.000 6/21 28.6 0.014 7/16 43.7 0.0005
Planning 10 6/38 15.8 0.270 4/21 19.0 0.152 2/17 11.8 0.684 
Organization 
of Materials 10 7/38 18.4 0.098 4/21 19.0 0.152 3/17 17.6 0.238 
Monitor 10 7/38 18.4 0.098 4/21 19.0 0.152 3/17 17.6 0.238 
MCI 10 11/38 28.9 0.001 6/21 28.6 0.014 5/17 29.4 0.022 
GEC 10 9/38 23.6 0.011 6/21 28.6 0.014 3/17 17.6 0.238 
Significance is determined if the percentage of study patients with T scores ≥ 65 percentile is 
greater than the expected 10%. 
A - Bold numbers indicate statistical significance. 
 
 The parent BRIEF was also analyzed to describe neurocognitive functioning in 
the study population. Parents reported impaired scores for 23.6% of the study population 
on the Global Executive Composite (GEC) scale, which includes all of the subscales.  For 
the cohort of forty-one patients, 31.5% showed impaired scores on the Behavior 
Regulation Index (BRI), with clinically significant endorsement of problems on the 
inhibit (21.1%) and shift (34.2%) scales.  On the Metacognition Index (MI), 28.9% of the 
population showed impairment, with clinically significant scores on the memory sub-
scale (35.1%) (see Table 5). 
 The results of the parent-version survey instruments were also divided into 
subgroups of gender, age at diagnosis and age at study completion and analyzed for 
comparison to further characterize the study population.  When the results of the parent- 
report BASC-II were divided by gender, female patients (40.9%) endorsed more 
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internalizing symptoms than male patients (11.1%), as confirmed by Fisher’s test (p = 
0.073).  Specifically, female patients endorsed more symptoms of depression (40.9%), 
somatization (40.9%) and withdrawal (36.4%) than their male counterparts (22.22%, 
22.22% and 22.22% respectively).  Male patients endorsed more problems with attention 
(33.3%), activities of daily living (33.3%) and overall impairment on the behavioral 
symptoms index (33.3%) than female patients (22.7%, 13.6% and 22.7% respectively).   
Fisher’s tests performed for this data were not clinically significant (see Table 4). 
 The results of the parent report of the BRIEF, when divided by gender, revealed 
greater proportion of impairment in female patients on the GEC (28.6%) and BRI 
(33.3%) than male patients (17.6% and 29.4% respectively).  Male patients had slightly 
higher percentage of problems with shift (35.3%) and memory (43.7%) than female 
patients (33.3% and 28.6% respectively).  However female patients endorsed more 
problems with inhibition (23.8%) than male patients (17.6%).  Fisher’s tests were run 
comparing percentage of impairment in male and female patients, and revealed no 
clinically significant differences (see Table 5). 
 When the results of the parent-report BASC-II were divided by age at diagnosis, 
children diagnosed at greater than or equal to 3.5 years were reported to have more 
symptoms of withdrawal (52.9%) than those diagnosed at younger ages (13%).  This was 
confirmed by Fisher’s test (p-value = 0.013).  Children diagnosed in the older age group 
also were reported on the parent BASC-II to have more symptoms of anxiety (35.3%), 
depression (35.3%), atypicality (35.3%), internalizing problems (41.2%) and problems 
with attention (41.2%), adaptability (35.3%), and on the overall behavioral symptoms  
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Table 6 - Emotional Functioning as Measured by the Parent Version of the Behavior 
Assessment Scale for Children, Second Edition (BASC-II), Stratified by Age at 
DiagnosisA  
    Age at Diagnosis 
  Norm < 3.5 yrs ≥ 3.5 yrs 
  % #/N % 
p (vs. 
norm) #/N % 
p (vs. 
norm) 
Externalizing Problems 16 3/23 13 1.000 2/17 11.8 1.000 
     Hyperactivity 16 2/23 8.7 0.567 3/17 17.6 0.745 
     Aggression 16 2/23 8.7 0.567 2/17 11.8 1.000 
     Conduct Problems 16 3/23 13 1.000 4/17 23.5 0.336 
Internalizing Problems 16 4/23 17.4 0.778 7/17 41.2 0.012 
     Anxiety 16 1/23 4.3 0.160 6/17 35.3 0.042 
     Depression 16 7/23 30.4 0.080 6/17 35.3 0.042 
     Somatization 16 8/23 34.8 0.022 5/17 29.4 0.174 
Behavioral Symptoms Index 16 5/23 21.7 0.400 6/17 35.3 0.043 
     Atypicality 16 3/23 13 1.000 6/17 35.3 0.042 
     Withdrawal 16 3/23 13 1.000 9/17 52.9 0.000 
     Attention Problems 16 4/23 17.4 0.778 7/17 41.2 0.012 
Adaptive Skills Composite 16 6/23 26.1 0.247 4/17 23.5 0.336 
     Adaptability 16 3/23 13 1.000 6/17 35.3 0.042 
     Social Skills 16 3/23 13 1.000 4/17 23.5 0.336 
     Leadership 16 5/23 21.7 0.400 3/17 17.6 0.745 
     Activities of Daily Living 16 6/23 26.1 0.247 3/17 17.6 0.745 
     Functional Communication 16 4/23 17.4 0.778 5/17 29.4 0.174 
Significance is determined if the percentage of study patients with T scores ≥ 84 
percentile (≤ 16 percentile for adaptive scales) is greater than the expected 16%. 
A - Bold numbers indicate statistical significance. 
 
index (35.3%) than patients diagnosed at ages younger than 3.5 (4.3%, 30.4%, 13%, 
17.4%, 17.4%, 13%, and 21.7% respectively).   Conversely, on the BASC-II, parents 
reported that children diagnosed before age 3.5 showed more symptoms of somatization 
(34.8%) than those diagnosed at older ages (29.4%).  These results were not significantly 
different by Fisher’s test (see Table 6).  
 When divided by age at study completion, parents reported that pre-adolescent 
patients endorsed more symptoms of somatization (37.5%) than adolescent patients 
(29.2%).  However, adolescents were reported by their parents on the BASC-II to exhibit 
more symptoms of depression (33.3%) and withdrawal (33.3%) than pre-adolescents.   
These differences were not significant when compared by Fisher’s tests. 
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Table 7 - Neurocognitive and Executive Functioning as Measured by the Parent 
Version of the Behavior Rating Index of Executive Functioning (BRIEF), Stratified 
by Age at Diagnosis and Age at Study CompletionA  
  Age at Diagnosis Age at Study Completion 
  < 3.5 yrs ≥ 3.5 yrs ≤ 11 yrs ≥ 12 yrs 
  #/N % p  #/N % p  #/N % p  #/N % p  
Inhibit 2/20 10.0 1.000 6/18 33.3 0.006 1/16 6.3 1 7/22 31.8 0.004 
Shift 5/20 25.0 0.043 8/18 44.4 0.000 4/16 25.0 0.07 9/22 40.1 0.0001 
Emotional 
Control 3/20 15.0 0.445 4/18 22.2 0.098 2/16 12.5 0.67 5/22 22.7 0.062 
BRI 5/20 25.0 0.043 7/18 38.9 0.001 3/16 18.6 0.21 9/22 40.1 0.0001 
Initiation 2/20 10.0 1.000 4/18 22.2 0.098 2/16 12.5 0.67 4/22 18.2 0.27 
Working 
Memory 4/20 20.0 0.133 9/17 52.9 0.000 3/16 18.6 0.21 
10/2
2 45.5 0 
Planning 3/20 15.0 0.445 3/18 16.7 0.146 1/16 6.3 1 5/22 22.7 0.062 
Org, of 
Materials 3/20 15.0 0.445 4/18 22.2 0.098 3/16 18.6 0.21 4/22 18.2 0.27 
Monitor 2/20 10.0 1.000 5/18 27.8 0.028 2/16 12.5 0.67 5/22 22.7 0.062 
MCI 4/20 20.0 0.133 7/18 38.9 0.001 4/16 25.0 0.07 7/22 31.8 0.004 
GEC 3/20 15.0 0.445 6/18 33.3 0.006 2/16 12.5 0.67 7/22 31.8 0.004 
Significance is determined if the percentage of study patients with T scores ≥ 65 percentile is greater 
than the expected 10%.  P-value is as compared to the norm, which was 10% for each analysis.  Org. 
of Materials refers to Organization of Materials. 
A - Bold numbers indicate statistical significance. 
  
 When results of the BRIEF were analyzed by age at diagnosis, parents reported a 
higher percentage of impairment of working memory in children diagnosed at age 3.5 or 
older (52.9%) than those in the younger age at diagnosis group (20.0 %).  This clinically 
significant difference was confirmed by Fisher’s test (p-value = 0.047).  Children 
diagnosed at age 3.5 or older also had more problems with inhibition (33.3%), shift 
(44.4%), and monitor (27.8%) compared to the younger population (10%, 25% and 10% 
respectively).  Parents reported higher rates of impairment in children diagnosed at 3.5 
years or older on the summary scales of the behavioral regulation index (38.9%), 
metacognition index (38.9%), and global executive composite (33.3%) than in children 
diagnosed before 3.5 years of age (25%, 20%, and 15% respectively) (see Table 7). 
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Table 8 - Self-Report of Quality of Life as Measured by the Pediatric Quality of Life 
Inventory (PedsQL), Stratified by GenderA 
  Norm All Patients Female Male 
  
% #/N % p (vs. norm) #/N % 
p (vs. 
norm) #/N % 
p (vs. 
norm)
Physical 
Functioning 15 13/40 32.5 0.006 9/22 40.9 0.002 4/18 22.2 0.333 
Emotional 
Functioning 14 12/40 30.0 0.009 10/22 45.5 0.0003 2/18 11.1 1 
Social 
Functioning 16 11/40 27.5 0.053 6/22 27.3 0.149 5/18 27.8 0.192 
School 
Functioning 17 12/40 30.0 0.035 6/22 27.3 0.249 6/18 33.3 0.106 
Psychosocial 
Summary 
Score 
16 10/40 25.0 0.129 7/22 31.8 0.071 3/18 16.7 1 
Total Score 17 13/40 32.5 0.018 8/22 36.4 0.023 5/18 27.8 0.214 
Higher Z-scores indicate better quality of life.  Significance is determined if the percentage 
of study patients is greater than the expected percentile listed in the Norm column.  The 
expected percentiles change with each subscale. 
A - Bold numbers indicate statistical significance. 
 
 The results of the self-report PedsQL were also compared to normative 
populations in order to characterize quality of life functioning in the study population and 
to prepare for analyses of the three aims.  On the self-report PedsQL, 32.5% showed 
impairments on the total score scale, with clinically significant impairments in emotional 
(30.0%), social (27.5%), and school (30.0%) functioning.  This indicated that the 
impairments reported could affect any of the realms of quality of life (see Table 8). 
 The results of the self-report PedsQL were also divided into subgroups and 
compared to healthy controls.  When divided by gender, female patients showed more 
impairment on the total score (36.4%) than male patients (27.8%).  Female patients also 
endorsed more clinically significant impairment on the emotional (45.5%) functioning 
scales than male patients (11.1%), as confirmed by Fisher’s test (p = 0.035) (see Table 8).  
 When separated by age at diagnosis, children who were diagnosed at 3.5 years or 
older reported greater impairment in every realm -- emotional functioning (33.3%), social  
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Table 9 - Self-Report of Quality of Life as Measured by the Pediatric Quality of Life 
Inventory (PedsQL), Stratified by Age at DiagnosisA 
    Age at Diagnosis 
  Norm < 3.5 yrs ≥ 3.5 yrs 
  % #/N % p  (vs. Norm)  #/N % 
p  
(vs. Norm) 
Physical Functioning 17 6/22 27.3 0.128 7/18 38.9 0.012 
Emotional Functioning 16 6/22 27.3 0.113 6/18 33.3 0.031 
Social Functioning 19 4/22 18.2 0.77 7/18 38.9 0.017 
School Functioning 19 5/22 22.7 0.406 7/18 38.9 0.023 
Psycho-social Summary Score 18 5/22 22.7 0.381 5/18 27.8 0.192 
Total Score 18 6/22 27.3 0.249 7/18 38.9 0.023 
Higher Z-scores indicate better quality of life.  Significance is determined if the percentage of 
study patients is greater than the expected percentile listed in the Norm column.  The expected 
percentiles change with each subscale. 
A - Bold numbers indicate statistical significance. 
 
functioning (38.9%) and school functioning (38.9%) than those diagnosed before age 3.5 
(27.3%, 27.3%, 18.2%, 22.7% respectively).  This was also reflected in greater 
impairment in total score in older age at diagnosis (38.9%) than younger age at diagnosis 
(27.3%) (see Table 9). When divided by age at evaluation, pre-adolescent patients 
reported clinically significant percentages of impairment in emotional functioning 
(33.3%) while adolescent patients did not (24% and 28% respectively).  
 The remaining sets of surveys -- the teacher-report and self-report versions of the 
BASC-II, the teacher version of the BRIEF, and the parent version of the PedsQL -- were 
also scored and compared to normative populations.  The results of these instruments 
were divided into subgroups and compared for differences.  The data from these surveys 
was mostly used to characterize the study population, and can be found in Appendix I for 
further reference. 
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Perceptions of Impairment and Inter-Rater Reliability  
 Key data from the different versions of each survey instrument were analyzed to 
determine if there was inter-observer reliability and agreement.  Differences in perception 
of impairment based on the respondent were evaluated with kappa statistics, which 
analyze agreement.  First, agreement was analyzed on the attention subscale on the parent 
and teacher versions of the BASC-II (see Appendix I for results of teacher-report BASC-
II).  This analysis showed that of the seven patients rated as impaired by parents, teachers 
rated 4 as impaired (kappa = 0.57, p = 0.0015), indicating moderate strength of 
agreement with a significant p-value labeling this result as not due to chance alone (see 
Table 10). 
 The parent and child versions of the BASC-II were also evaluated to determine if 
the raters agreed on the attention and emotional functioning scales (see Appendix I for 
results of the self-report BASC-II).  When parents rated attention as impaired (N = 11), 
children rated themselves as impaired 7 times (kappa = 0.59, p = 0.0001), indicating 
moderate strength of agreement not due to chance.  However, there was no strength of 
agreement shown for the depression, anxiety, somatization, or internalizing symptoms 
scales (see Table 10). 
 The parent and teacher versions of the BRIEF were analyzed to understand 
perceptions of executive functioning (see Appendix I for results of the teacher-report 
BRIEF).  Of the 9 survivors rated as having problems with memory by parents, five were 
rated as impaired by teachers (kappa = 0.61, p = 0.0006), showing substantial strength of 
agreement not due only to chance.  The level of agreement was moderate for shifting 
behaviors, as parents rated children as having problems seven times and teachers also 
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Table 10 - Inter-rater Reliability Between Different RespondentsA 
Perceptions of Impairment KappaE P-value 
Parent BASC vs. Teacher BASC   
     Attention 0.57 0.002 
Parent BASC vs. Self-Report BASC   
     Depression 0.08 0.295 
     Anxiety 0.21 0.098 
     Attention 0.59 0.000 
     Somatization 0.10 0.265 
     Internalizing Symptoms 0.00 0.487 
Parent BRIEF vs. Teacher BRIEF   
     Memory 0.61 0.001 
     Inhibition 0.05 0.3925 
     Shift 0.43 0.011 
     Planning 0.52 0.002 
     Organization of Materials -0.07 0.672 
     Initiation 0.35 0.037 
     Monitor 0.17 0.191 
     Metacognition Index 0.52 0.002 
     Global Executive Composite 0.59 0.001 
Parent PedsQL vs. Self-Report PedsQL   
     School Functioning 0.70 0.000 
     Emotional Functioning 0.48 0.001 
     Social Functioning 0.44 0.002 
Self-Report PedsQL School Functioning vs. Teacher BRIEF   
     Memory 0.57 0.002 
     Planning 0.57 0.002 
     Organization of Materials 0.12 0.738 
     Initiation 0.40 0.022 
A - Bold numbers indicate statistical significance. 
E - Kappa Statistics were used to analyze the agreement against what might be 
expected by chance alone.  For these results, Kappa values from 0.41-0.60 were 
considered moderate agreement and from 0.61-0.80 were considered substantial 
agreement. Kappa values from 0.81-1.00 indicated almost perfect agreement. 
 
rated impairment 3 times (kappa  = 0.43, p = 0.011).  In terms of problems with planning, 
for the 2 patients parents rated as impaired, teachers rated both as impaired (kappa = 0.52, 
p = 0.0016) indicating moderate strength of agreement despite small numbers.  Of the 7 
patients parents rated as having impairments on metacognition, 3 were also rated as 
impaired by teachers (kappa = 0.52, p = 0.0015).  Similarly, of the 5 patients parents 
rated as having impairments on the global executive composite, 3 were rated as impaired 
by teachers (kappa = 0.59, p = 0.0013).  These results indicate moderate strength of 
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agreement not due only to chance.  There was no agreement shown in terms of inhibition, 
organization of materials, initiation or monitor (see Table 10). 
 The parent and self-report versions of the PedsQL were analyzed to assess 
variability in perceptions of quality of life and showed agreement in all realms (see 
Appendix I for results of the parent-report PedsQL).  The level of agreement was 
substantial for impairment of school functioning, as of the 11 reports of impairment by 
parents, children also rated impairment 9 times (kappa = 0.70, p = 0.000).  Among the 15 
patients reported as having impaired emotional functioning by parents, 8 children self-
reported impairment (kappa = 0.48, p = 0.0013).  Parents reported impairment in social 
functioning in 15 patients, and of these 8 self-reported impairment (kappa = 0.44, p = 
0.0023).  These results show moderate agreement for emotional and social functioning 
between parents and survivors not due to chance alone (see Table 10). 
 Due to the limitations of the surveys, in order to understand different perceptions 
of school functioning between the child and the teacher, the self-report of school 
functioning on the PedsQL was compared to the teacher version of the BRIEF (see 
Appendix I for results of the teacher-report BRIEF).  Among those patients reporting 
impaired school functioning (N = 7), teachers reported impairments in memory in 4 
patients (kappa = 0.56, p = 0.0019) and impairments in planning and organization in 4 
patients (kappa = 0.56, p = 0.0019).  These results indicate moderate strength of 
agreement not due to chance.  There was no agreement between self-report of impaired 
school functioning and teacher perception of problems with organization of materials or 
initiation (see Table 10). 
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Co-morbidities between Neurocognitive and Emotional Impairments 
 Data was compared between survey instruments in order to determine which 
emotional problems tended to co-exist alongside neurocognitive difficulties.  The anxiety 
and depression scales on the parent BASC-II were compared to executive functioning 
scales on the parent version of the BRIEF.  Among the 14 patients reported by their 
parents to have impairments in either anxiety or depression on the BASC-II, 57.1% (N = 
8, p-value = 0.039) had co-existing impairment in shift, defined as ability to freely shift 
between activities, on the BRIEF.  Parent reports did not show that anxiety and 
depression co-existed with memory, organization of materials, initiation, monitor, 
inhibition or the metacognition index (see Table 11).  
 Among the 13 patients reported to have impairments in somatization on the 
BASC-II, 61.5% (N = 8, p = 0.03) had co-existing impairments in memory, 69.2% (N = 
9, p = 0.003) had co-existing impairments in shift, and 53.9% (N = 7, p = 0.028) had co-
existing impairments on the metacognition index on the BRIEF.  Within the group of 
parent reports of impaired somatization on the BASC-II, parents did not rate impairments 
in organization of materials, initiation, monitor, or inhibition as significantly impaired on 
the BRIEF (see Table 11). 
 Of the 12 patients rated by their parents as impaired on the withdrawal scale on 
the BASC-II, 66.7% (N = 8, p = 0.011) had co-existing impairments in memory, 66.7% 
(N = 8, p = 0.011) had co-existing impairments in shift and 58.3% (N = 7, p = 0.018) had 
co-existing impairments on the metacognition index shift.  Within this group there was no 
co-existence shown with organization of materials, initiation, monitor and inhibition as 
significantly higher rates of impairment than no impairment (see Table 11). 
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Table 11 - Co-existence of Impairments in Emotional and Neurocognitive 
OutcomesA 
Co-Morbidities: Parent BASC-II vs. Parent BRIEF ProportionF (%) P-value 
Anxiety and Depression vs.    
     Memory 42.9 0.723
     Organization of Materials 35.7 0.080
     Initiation 21.4 0.653
     Shift 57.1 0.039
     Monitor 35.7 0.080
     Inhibition 21.6 0.215
     Metacognition Index 50.0 0.063
Somatization vs.    
     Memory 61.5 0.030
     Organization of Materials 38.5 0.072
     Initiation 46.2 0.001
     Shift 69.2 0.003
     Monitor 38.5 0.072
     Inhibition 30.8 0.413
     Metacognition Index 53.9 0.028
Withdrawal vs.    
     Memory 66.7 0.011
     Organization of Materials 33.3 0.183
     Initiation 41.7 0.009
     Shift 66.7 0.010
     Monitor 50.0 0.002
     Inhibition 33.3 0.394
     Metacognition Index 58.3 0.018
Internalizing Symptoms vs.     
     Memory 45.5 0.475
     Organization of Materials 36.4 0.163
     Initiation 27.3 0.335
     Shift 72.7 0.006
     Monitor 45.5 0.016
     Inhibition 36.4 0.203
     Metacognition Index 54.6 0.051
A - Bold numbers indicate statistical significance. 
F - Proportion is described as the following: of those who are reported by parents to be 
impaired on the BASC-II, the proportion also reported by parents as impaired on the 
BRIEF.  For example, among the 14 patients reported to have impairments in either 
anxiety or depression on the BASC-II, 57.1% (N = 8, p-value = 0.039) had co-existing 
impairment in shift on the BRIEF.  Fisher’s exact test was used for this analysis. 
 
 Among the 11 patients whose parents reported impairment in internalizing 
symptoms on the BASC-II, 72.7% (N = 8, p = 0.006) had co-existing impairments in shift 
on the BRIEF.  Within this group of parent reports there was no co-existing impairment 
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shown in memory, organization of materials, initiation, monitor, inhibition or on the 
metacognition index (see Table 11). 
 
Predictors of Poor Quality of Life  
 An unadjusted and an adjusted logistic regression was performed in order to 
determine the extent to which factors of female gender, adolescent age at study 
completion, parent-rating of impaired metacognition and parent-rating of endorsement of 
internalizing symptoms were associated with self-perception of poor quality of life.  
Specifically, the realms of school functioning, emotional functioning and social 
functioning were examined from the results of the self-report PedsQL.  Age at study 
completion was chosen instead of age at diagnosis due to high correlation between the 
two realms and better data in the literature about the significance of age at testing in 
revealing late effects of childhood cancer treatments.   
Worse school functioning was predicted by impaired metacognition on the parent 
BRIEF in the unadjusted model (OR = 23, CI = 3.52-150.48, p = 0.001).  When adjusted 
for the other predictors, the odds ratio (OR) increased (OR = 33.5, CI = 3.2-351.39, p = 
0.003), indicating that metacognition was a very strong predictor of poor school 
functioning.  Female gender, age at testing and parent rated impairment of internalizing 
symptoms on the BASC-II were not good predictors of school functioning (see Table 12). 
Poor emotional functioning was also predicted by parent-rating of impaired 
metacognition on the BRIEF on the unadjusted model (OR = 5.25, CI 1.11-24.91, p = 
0.037).  When adjusted for the other predictors, the odds ratio increased (OR = 11.48, CI 
= 1.07-123.17, p = 0.044), indicating that impaired metacognition was a strong  
 46
Table 12 - Predictors of Self-Report of Impaired Quality of Life Functioning Among 
Survivors, Unadjusted and Adjusted Regression AnalysisA  
  Unadjusted Adjusted 
  OR (95% CI) P-value OR (95% CI) P-value
School Functioning     
Female Gender 0.79 (.02-3.12) 0.73 1.18 (0.18-7.61) 0.86 
Age at Testing >= 12 1.57 (0.37-6.61) 0.54 1.39 (0.22-8.94) 0.73 
Parent-rated Impairment of 
MetacognitionG 23.00 (3.52-150-48) 0.001 33.51 (3.2-351.39) 0.003 
Parent-rated Impairment in Internalizing 
SymptomsH 1.50 (0.33-6.82) 0.6 0.34 (0.03-4.39) 0.41 
Emotional Functioning     
Female Gender 7.50 (1.35-41.72) 0.021 15.58 (1.41-172.85) 0.025 
Age at Testing >= 12 0.93 (0.23-3.78) 0.92 0.56 (0.09-3.53) 0.54 
Parent-rated Impairment of 
MetacognitionG 5.25 (1.11-24.91) 0.037 11.48 (1.07-123.17) 0.044 
Parent-rated Impairment in Internalizing 
SymptomsH 5.00 (1.05-23.79) 0.043 2.11 (0.33-13.58) 0.43 
Social Functioning     
Female Gender 1.03 (0.25-4.24) 0.97 1.07 (0.17-6.77) 0.94 
Age at Testing >= 12 0.75 (0.18-3.12) 0.69 0.38 (0.06-2.48) 0.31 
Parent-rated Impairment of 
MetacognitionG 13.42 (2.40-74.89) 0.003 13.94 (2.00-97.22) 0.008 
Parent-rated Impairment in Internalizing 
SymptomsH 3.33 (0.72-15.54) 0.125 2.17 (0.3-15.64) 0.44 
A - Bold numbers indicate statistical significance. 
G - As measured on the parent-report version of the Behavior Rating Inventory of Executive 
Function. 
H - As measured on the parent-report version of the Behavior Assessment Scale for Children, 
Second Edition. 
 
predictor of poor emotional functioning.  Worse emotional functioning was predicted by 
female gender on the unadjusted model (OR = 7.5, CI = 1.35-41.72, p = 0.021) and when 
adjusted for the other predictors (OR = 15.58, CI = 1.41-172.85, p = 0.025), indicating 
that female gender was also a strong predictor for poor emotional functioning.  Poor 
emotional functioning was predicted by parent-rating of endorsement of internalizing 
symptoms on the BASC-II in the unadjusted model (OR = 5, CI 1.05-23.79, p = 0.043).  
However, when adjusted for other factors, impairment in internalizing symptoms was not 
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as good of a predictor (OR = 2.11, CI = 0.33-13.58, p = 0.43).  Age at testing was not a 
good predictor of emotional functioning (see Table 12). 
Poor social functioning was only predicted by impaired metacognition as reported 
by parents on the BRIEF.  On the unadjusted model, impaired metacognition predicted 
poor social functioning (OR = 13.42, CI = 2.40-74.89, p = 0.003), and this remained true 
when adjusted for the other predictors (OR = 13.94, CI = 2.00-97.22, p = 0.008).  Poor 
self-report of social functioning was not predicted by age at testing, female gender, or 
parent rated impairment of internalizing symptoms on the BASC-II (see Table 12). 
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Discussion 
In this single institution cross-sectional study of forty-one childhood cancer 
survivors who were simultaneously assessed for neurocognitive processing, emotional 
functioning, and quality of life, a better understanding of psychosocial functioning in 
childhood cancer survivors was obtained.  This was accomplished through reaching the 
three proposed aims of the study.   
In accomplishing the first aim of the study, modest inter-observer variability was 
found, especially among indexes of emotional symptoms.  Moderate levels of agreement 
were found between parent and teacher reporting on the BASC-II and BRIEF in terms of 
attention, memory, ability to freely shift between behaviors, planning, metacognition and 
global executive functioning.  However, when reporting inhibition, monitoring and 
initiation of behaviors, and organization of materials, agreement was not shown.  
Similarly there was moderate strength of agreement in memory and planning between 
teacher perceptions of executive functioning on the BRIEF and self-report of school 
functioning on the PedsQL, but reports of other realms of executive functioning did not 
show agreement. 
These results reveal differences in perception between reports from teachers and 
reports from parents and patients.  Overall, teachers did not report as many deficits as 
parents or children.  This could indicate that the problems children report are sub-clinical 
or potentially partially compensated for by diligent effort, and therefore are unable to be 
perceived by teachers in the school setting.  Internalizing symptoms and psychosocial 
deficits may be more difficult for teachers to assess, as they only see children in the 
limited school environment.  Similarly, given the activities at school, problems with 
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memory and attention may be easier to perceive than impairments in other realms of 
executive functioning, such as problems with initiation, inhibition, shift, planning and 
organization.  Supporting the findings of other studies, the results of the current study 
indicate that survivors’ deficits are less pronounced in some settings than others (19, 41).  
Additionally, these results could also reveal that teachers are not getting to know their 
students well enough.  Teachers may need to delve deeper with cancer survivors to 
ensure that they do not miss symptoms or problems with which the students could benefit 
from help.  Due to varying expression of symptoms in different settings and the 
variability in perceptions of impairment between teachers and parents and children, 
feedback about children’s well-being from a variety of complementary sources is 
necessary to fully assess functioning. 
Parent and self-reporting also lacked agreement in some realms of functioning.  In 
analyses of emotional symptoms on the BASC-II, there was moderate agreement only on 
the attention scale.  Inter-rater variability existed for the remaining emotional symptom 
scales, such as depression, anxiety, somatization, and internalizing symptoms.  On the 
PedsQL, however, there was agreement between parents’ perceptions and children’s self-
perceptions of their quality of life in every area of functioning.  Despite the small sample 
size, reports of school functioning showed substantial agreement and reports of emotional 
and social functioning showed moderate agreement by kappa statistics. 
Inter-rater agreement was found for quality of life functioning, but not for specific 
emotional symptoms.  Children perceive that they are not doing well, and parents tend to 
agree with them.  However, when parents recognize specific internalizing symptoms 
exhibited by their children, the survivors do not report the same impairment.  This could 
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represent a lack of ability to definitively identify symptoms, even when children sense 
poor quality of life.  As Wheeler and Ladd described, parents’ perceptions of ability in 
performing specific tasks correlates better with children’s actual abilities than do 
children’s own perceptions (47).  Children may not always have the capacity to pinpoint 
specific deficits, but are able to sense overall deficit.  Previous studies have also shown 
that childhood cancer survivors feel more apprehension and tension than age-matched 
peers (17) and often underestimate their abilities (44, 45).  The results of the current 
study may therefore indicate a tendency to overestimate poor quality of life, even when 
children do not endorse specific symptoms, due to increased levels of apprehension.  
However independent of cause, it is important to understand children’s self-perceptions 
of their feelings because this determines their self-efficacy and subsequent behaviors. 
These results could also indicate over-reporting of specific symptoms by parents 
due to their own biases.  Parents are affected by a child having had cancer, as evidenced 
by more reported symptoms of post-traumatic stress disorder in mothers of survivors than 
parents of healthy children (56, 57).  Parents may, when completing surveys about their 
children’s behaviors, overestimate the presence of symptoms.  This could stem from 
knowledge that their child has had an illness experience or the subsequent hyper-
vigilance instilled by parents experiencing post-traumatic stress.  Significant associations 
between survivors’ psychological and behavioral adjustment and parental psychological 
distress and coping strategies have previously been reported (58).  A parent may perceive 
symptoms in a child as a projection of his or her own psychosocial functioning and 
feelings about a situation.  Given the combination of children’s potential deficits in 
identifying or overestimating functioning and parent’s own biases based on their 
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experiences, the results of this study highlight the need to include perceptions of 
functioning from a variety of sources in order to fully understand a survivor’s emotional 
and social state. 
Beyond exhibiting the need for multiple perceptions to determine functioning, the 
current study provides a better understanding of impairments by detailing co-morbidities 
of deficits.  In reaching the second aim of the study, the present research showed that, as 
a whole, neurocognitive and emotional difficulties did not co-exist.  Impairments of 
internalizing symptoms and of anxiety and depression co-existed only with impairments 
in shift and not with any other realm of executive functioning.  More targeted emotional 
symptoms, such as symptoms of somatization and social withdrawal, co-existed with 
problems with memory, shift, initiation and coordination of problem-solving behaviors.  
In the overall population, anxiety and depression often coincide with social withdrawal 
and symptoms of somatization (11, 12).  However, the current study indicates that 
childhood cancer survivors who exhibit problems with executive functioning might be 
more socially withdrawn and over-sensitive to physical complaints, but do not exhibit 
signs of anxiety or depression.  These results help elucidate reasons behind specific 
emotional impairments.  Symptoms of somatization or social withdrawal may stem from 
underlying difficulties with neurocognition, as children are self-conscious about their 
impaired executive functioning.  However these neurocognitive deficits do not result in 
clinically significant anxiety or depression.  Knowledge of these co-morbidities can be 
used to determine targeted treatments for different sets of impairments.  
The ultimate downstream outcome of these deficits, survivor perception of quality 
of life, was measured by the self-report PedsQL and used to accomplish the study’s third 
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aim.  Interestingly, neurocognitive impairment was again the causative factor.  
Neurocognitive deficits, as measured by the metacognition index on the BRIEF, were 
consistently associated with worse school, emotional, and social quality of life.  In the 
present study, problems with metacognition, an analysis of a child’s ability to plan and 
initiate problem-solving, were shown to profoundly impact the child’s self-perception of 
his or her overall competence.  As Bandura reported in 1977, self-efficacy is impacted by 
the child’s experiences, which ultimately shapes his or her behaviors and coping 
mechanisms (46).  Neurocognitive problems clearly play a role in a child’s experiences.  
Problems with neurocognition and executive functioning can have a direct impact on 
academic performance, and therefore self-perception of school functioning.  Emotional 
functioning may be depressed due to a child’s awareness of and feelings about his or her 
deficits in neurocognition, and from the social withdrawal and symptoms of somatization 
that co-exist with neurocognitive problems.  
Similarly, children may feel less capable or socially awkward because of their 
difficulties with executive functioning, and this can impact self-esteem, interactions with 
peers and, eventually, overall social functioning.  Previous studies have describe that, as a 
whole, childhood cancer survivors have fewer friends, are less satisfied with their 
relationships, and spend more time by themselves than their peers (19, 24).  The current 
study showed that impairments in withdrawal co-exist with neurocognitive difficulties 
and problems with executive functioning predict poor social functioning.  Self-efficacy, 
here measured by the self-report PedsQL, drives social competence.  Survivors who 
suffer from neurocognitive deficits may feel less comfortable with themselves, creating a 
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tendency toward social withdrawal.  This ultimately results in poor emotional and social 
functioning that may impact survivors’ quality of life as a whole. 
Impaired metacognition was a stronger predictor of emotional quality of life than 
endorsement of emotional symptoms as measured by the BASC-II.  While impaired 
internalizing symptoms on the BASC-II predicted poor emotional functioning in the 
unadjusted analysis, this did not remain true when adjusted for other factors.  
Endorsement of emotional symptoms also did not predict worse school or social 
functioning.  Feelings of anxiety, depression, withdrawal and somatization can clearly 
impact a child’s emotional quality of life.  However these symptoms are neither the only 
nor the greatest cause of dissatisfaction with emotional functioning.  Interventions 
targeting internalizing symptoms may help improve emotional quality of life, but co-
existing deficits need to be screened for to ensure proper treatment for these patients.  
Additional research is necessary to further characterize and understand the impact of 
these symptoms on childhood cancer survivors. 
Unlike endorsement of internalizing symptoms, female gender was found to be a 
predictor of poor emotional functioning in both the unadjusted and adjusted analyses.  
Parents reported that female patients endorsed more internalizing symptoms and 
problems with behavioral regulation and inhibition than male patients, and female 
patients and their parents both reported worse quality of life functioning.  This is 
consistent with previous studies reporting that female patients endorse more internalizing 
symptoms, including depression, anxiety and somatic distress (7, 8, 14, 59).  However 
these results also reveal that not only do female patients report more late effects than 
male patients, but these deficits are also correlated with impaired self-perception of 
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emotional quality of life.  Due to societal norms, female patients may be more willing to 
admit to problems with emotional functioning than male patients, which could bias these 
results.  Alternatively, female patients may internalize their illness experience in different 
ways than male patients, ultimately impacting their ability to cope and their emotional 
quality of life.  However, independent of the reason behind these results, emotional 
functioning is highlighted as an area of deficit that needs to be targeted in female 
survivors. 
Age at study completion was also analyzed, and neither adolescent nor pre-
adolescent age at study completion was shown to be a predictor of self-perception of poor 
quality of life.  These results were surprising, as parents reported more impairment in 
quality of life functioning, as well as more symptoms of withdrawal, anxiety, depression, 
atypical behaviors and internalizing symptoms, in adolescent patients than in pre-
adolescent patients.  However, it should be noted that adolescent patients did not self-
report these same results, and self-report of quality of life was used to determine 
predictors of functioning.  Adolescents may underreport difficulties or may not be as 
influenced by deficits as parents perceive them to be.  In 1982 Harter theorized that upon 
entering junior high school, due to the social and academic changes of this time period, 
children lose a percentage of their ability to accurately self-perceive their competence 
(48).  This theory could explain the discrepancy in parent and child reporting, as well as 
the conclusion that age was not a predictor of poor quality of life.  Further work is 
necessary to understand how patients of different ages view their quality of life and if 
interventions should be altered depending on patient age.   
 55
Due to a participation rate of only 53.2% and the small sample size, the authors of 
the current study were cautious about reporting frequencies of specific outcomes as being 
able to be generalized to both HEROS Clinic patients and all childhood cancer survivors.  
Therefore, a focus was placed on case-case comparisons rather than reports of overall 
risk.  Because of the heterogeneous cancer treatments received by patients in the sample, 
it was not possible to examine the role of various treatment characteristics in greater 
detail.  Instead, patients were grouped by broad categories based on if they had received 
cranial radiation or intrathecal chemotherapy.   
Patients who had received central nervous system-directed treatment were 
reported to have fewer problems with both school maladjustment and attitude towards 
teachers.  These results are not consistent with previous literature, which indicates 
increased risk for psychological and social difficulties in patients who received cranial 
radiation or intrathecal methotrexate (8, 33).  However, studies have also indicated that 
more intense or prolonged treatment is associated with poorer adjustment and greater 
endorsement of symptoms of psychological distress (60, 61).  Treatment intensity and 
duration were not analyzed in the current study, and could be confounding factors.  
Additionally, these therapies may render children more quiet and passive, making it more 
difficult for teachers, or even parents, to observe deficits.  Further analyses with the data 
reported here should take advantage of the simultaneous analysis of neurocognitive, 
emotional and quality of life functioning, one of the great strengths of the current study.  
Central nervous system-directed therapies should be evaluated as a predictor of worse 
self-report of quality of life in this population. 
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It is important to note the limitations of the current study.  Participation suffered 
from a high rate of passive refusal.  The majority of non-participants passively declined 
participation by neither returning the surveys mailed to them nor scheduling clinic 
appointments.  Recruitment by mail was inefficient, as only 13% of those contacted 
participated by mail, and the number of surveys returned by teachers was small, with only 
twenty-seven packets returned.  It is unknown if patients did not respond by mail due to 
lack of interest in the study or for other reasons.  When families completed surveys at 
home, they often reported forgetting about the study and needing reminders to return their 
answers.  This may indicate that patients to whom packets were mailed simply 
overlooked the study rather than actively deciding not to participate.  Of those patients 
who did actively decline, the reasons cited were that the parent did not desire for the child 
to have to think about the psychosocial side effects of his or her cancer or that the child 
was not interested in participating in a study. 
These reasons for declining of participation may highlight possible biases of the 
study population and of patients who choose to enroll in the HEROS Clinic.  As 
evidenced by the range of household incomes, the patients who attend the HEROS clinic 
tend to be middle-class, which is not representative of the entire population of survivors 
of childhood cancer.  Those who choose to participate may be more comfortable with 
their current quality of life and therefore willing to think about the issues raised by the 
surveys.  Alternatively, families of patients who attend clinic and agreed to complete the 
surveys may exhibit and observe more impairment, and therefore desired to participate in 
order to assist in discovering helpful interventions.  The current study may represent two 
ends of a spectrum and may under-represent patients with milder deficits that could play 
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a different role in quality of life than is reported in this study.  The current study also 
over-represents patients diagnosed with acute lymphoblastic leukemia compared to the 
non-participant group, which may have affected the results of the study. 
Despite these limitations, the current study provides an important addition to the 
literature about emotional and psychosocial functioning in childhood cancer survivors.  In 
accomplishing three aims, this study provides a better understanding of which symptoms 
endorsed by survivors have the greatest impact on how patients perceive their quality of 
life.  The current study shows inter-observer variability, especially among indexes of 
emotional symptoms, indicating a need to obtain and understand perspectives from 
multiple reporters to determine areas of deficit and true levels of functioning.  When 
taking care of survivors of childhood cancer, clinicians need to assess functioning from a 
variety of angles in order to fully address the needs of their patients.  Additionally, the 
current study reveals that certain neurocognitive and emotional deficits co-exist, while 
others do not.  Problems with memory, shift, initiation, and coordination of problem-
solving behaviors co-exist with symptoms of somatization and social withdrawal, but not 
with anxiety and depression.  Further, it is the neurocognitive rather than emotional 
symptoms that are shown to be key predictors of how child-age survivors perceive their 
quality of life after therapy.  These results indicate that problems in specific areas of 
executive functioning may help to explain somatization and social withdrawal behaviors, 
as well as poor quality of life in survivors.  Clinicians need to screen for co-morbidities in 
survivors who present with specific emotional or neurocognitive deficits in order to fully 
address both these impairments and issues of quality of life. 
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Despite the recognition of late effects of treatment for childhood cancer, the 
impact of these outcomes on children’s overall well-being has remained unclear.  The 
primary goal of therapy for childhood cancer is to cure the malignancy.  However, as 
cure rates improve, the concept of survivorship has expanded to include not only cure, 
but also global functioning after treatment.  Closely examining neurocognitive outcomes 
and showing that these deficits tend to predict self-reported worse global functioning, the 
current study helps develop a better understanding of quality of life in childhood cancer 
survivors.  Further research analyzing parent, teacher and self-report in a larger sample 
size would continue to clarify the discordance between perceptions of functioning and the 
benefits of these differences to patient care.  Furthermore, studies analyzing the effects of 
neurocognitive deficits on specific areas of global functioning could continue to elucidate 
co-morbidities of symptoms and ultimately determine treatments that can help survivors 
optimize their quality of life.   
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Appendix I 
 
Self-Report and Teacher-Report of Emotional Functioning on the BASC-II  
 Using the self-report versions of the BASC-II, there were no realms in which the 
percentage of impairment was statistically significant compared to the normative 
populations.  When divided by gender, patients did not report any symptoms of 
impairment at significantly higher rates than the published norms.  On the self report 
BASC-II children diagnosed at age 3.5 or older reported higher rates of problems with 
attention (33.3%) and hyperactivity (33.3%) compared to those diagnosed at younger 
ages (15% and 15% respectively).  This was not significant by Fisher’s test (p = 0.26).  
 By teacher report, patients did not show statistically significant impairment on 
any scale. When comparing female and male patients, a Fisher’s test revealed a 
statistically significant difference on the withdrawal scores (p = 0.047).  On the self and 
teacher versions of the BASC-II there were no statistically significant symptoms reported 
when divided by age at study completion. 
 When divided by history of central nervous system-directed therapy and 
comparing the means for each population, children who had received either cranial 
radiation or intrathecal chemotherapy reported fewer symptoms of school maladjustment 
(p value = 0.037) and problems with their attitudes towards teachers (p-value = 0.019) 
than those who did not. 
 
Teacher-Report of Executive Functioning on the BRIEF 
 As reported on the teacher version of the BRIEF, 28% of patients showed 
impairments on the initiation subscale.  Data analysis did not reveal any other realms in 
 60
which there was statistically significant impairment compared to the normative 
populations.  When divided by gender, male patients endorsed more problems with 
initiation (35.7%) and planning (28.6%) than female patients (18.2% and 9.1% 
respectively).  Fisher’s tests comparing male and female patients on these scales did not 
reveal statistically significant differences.  
 When divided by age at diagnosis, teachers reported higher rates of impairment in 
children diagnosed at age 3.5 years or older on the inhibit (30.8%), shift (30.8%) and 
initiation (30.8%) subscales, and on the BRI (30.8%) summary scale (compared to 0%, 
0%, 25% and 0% respectively in the younger population at diagnosis).  When separated 
by age at evaluation, teachers reported more endorsement of problems with shift (28.6%), 
initiation (35.7%), and planning (28.6%) in the adolescent population compared to pre-
adolescents (0%, 18.2% and 9.1% respectively).  Teachers also revealed significant 
percentages of impairment in adolescent patients on the BRI (28.6%) and GEC (28.6%).  
When analyzed by Fisher’s tests, no statistically significant differences were found. 
  
Parent-Report of Quality of Life Functioning on the PedsQL 
 On the parent report of survivors’ quality of life on the PedsQL, 36.6% of patients 
had impaired total scores and 34.1% had impaired psychosocial health summary scale 
scores.  Analysis of the study population revealed statistically significant proportion of 
impairment on the physical (29.3%), emotional (34.1%), and social (39.0%) functioning 
scales.  When divided by gender, female patients endorsed more impairment in overall 
quality of life (39.1%), emotional functioning (39.1%) and psychosocial health summary 
scale (34.7%) compared to their male counterparts (33.3%, 27.8% and 33.3% 
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respectively).  Male patients, however, showed greater endorsement of impairment in 
social functioning (44.4%) than female patients (34.7%).  Fisher’s tests did not show any 
statistically significant differences between male and female patients. 
 When divided by age at diagnosis, parents reported greater impairment of social 
functioning (44.4%) and on the psychosocial summary score (44.4%) and total score 
(44.4%) scales for children diagnosed at 3.5 years or older compared to those diagnosed 
at younger ages (34.8%, 26.1% and 30.4% respectively).  Children diagnosed before age 
3.5, however, endorsed greater difficulty with emotional functioning (34.8%) than those 
diagnosed at older ages (33.3%).  When separated by age at study completion, adolescent 
patients showed more impairment in emotional functioning (36%) and social functioning 
(40%) and on the psychosocial (36%) and total (36%) score scales than pre-adolescent 
patients (31.3%, 37.5%, 31.3% and 37.5% respectively).  There were no statistically 
significant differences in impairment when analyzed by Fisher’s tests. 
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